Expertise in
38
conditions

Dr. Joseph Merola

Dermatology
Brigham And Women's Hospital
221 Longwood Ave, 
Boston, MA 
Referral may be required
Expertise in
38
conditions
Brigham And Women's Hospital
221 Longwood Ave, 
Boston, MA 

Overview

Joseph Merola is a Dermatologist practicing medicine in Boston, Massachusetts.

Dr. Merola is highly rated in 38 conditions, according to our data. His clinical expertise encompasses Psoriasis, Psoriatic Arthritis, Cutaneous Lupus Erythematosus (CLE), and Arthritis.

He is actively involved in clinical research, co-authoring 435 peer reviewed articles and participating in 8 clinical trials.

Specialties

Dermatology

Licenses

Dermatology in MA

Hospital Affiliations

Parkland Health & Hospital System
UT Of Texas Southwestern University Hospital - William P. Clements Jr.

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Cook Children's Health Plan
  • MANAGED MEDICAID PLAN
EMI Health
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Martin's Point Generations
  • MEDICARE MAPD
  • OTHER MEDICARE
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 18 Less Insurance Carriers -

Locations

Brigham and Women's Hospital
221 Longwood Ave, Boston, MA 02115
Other Locations
Gary E Goff MD PA
5939 Harry Hines Blvd, Dallas, TX 75235

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Completed
Publish Date: November 05, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
A 2-Part Phase 2 Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of BIIB059 in Subjects With Systemic Lupus Erythematosus and Active Skin Manifestations and in Subjects With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations
Enrollment Status: Completed
Publish Date: November 07, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
A Phase 3, 16-week, Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Assess the Impact of Lebrikizumab on Vaccine Responses in Adult Patients With Moderate-to-Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Drug
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
Pro-Resolving Mediators in Acute Inflammation in Humans
Pro-Resolving Mediators in Acute Inflammation in Humans
Enrollment Status: Completed
Publish Date: May 26, 2022
Intervention Type: Other, Drug
Study Drug: Lovaza
Study Phase: Early Phase 1
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis, Dupilumab Study
Enrollment Status: Terminated
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 4
View 6 Less Clinical Trials

435 Total Publications

Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.
Targeted Therapy, Untargeted Rash: Insights From a GRAPPA Workshop on Immune Shifts in Psoriatic Disease.
Journal: The Journal of rheumatology
Published: June 15, 2026
Similar Doctors
Expertise in
29
conditions
Dr. Arash Mostaghimi
Dermatology
Expertise in
29
conditions
Dr. Arash Mostaghimi
Dermatology
Referral may be required

Brigham Dermatology Associates

221 Longwood Avenue 1st Floor Brigham And Women's At 221 Longwood Boston, 1st Floor Brigham And Women's At 221 Longwood, 
Boston, MA 
 (1547.2 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Arash Mostaghimi is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Mostaghimi is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Alopecia Areata, Autosomal Recessive Hypotrichosis, Pyoderma Gangrenosum, and Cellulitis. Dr. Mostaghimi is board certified in Dermatology, Internal Medicine, and Clinical Informatics.

Expertise in
26
conditions
Dr. Ruth A. Vleugels
Dermatology
Expertise in
26
conditions
Dr. Ruth A. Vleugels
Dermatology
Referral required

Brigham Dermatology Associates

221 Longwood Avenue 1st Floor Brigham And Women's At 221 Longwood Boston, 1st Floor Brigham And Women's At 221 Longwood, 
Boston, MA 
 (1547.2 miles away)
617-732-4918
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ruth Vleugels is a Dermatologist practicing medicine in Boston, Massachusetts. Dr. Vleugels is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Dermatomyositis, Discoid Lupus Erythematosus (DLE), Eosinophilic Fasciitis, and Cutaneous Lupus Erythematosus (CLE). Dr. Vleugels is board certified in Dermatology.

Expertise in
19
conditions
Dr. Nicole R. Leboeuf
Dermatology
Expertise in
19
conditions
Dr. Nicole R. Leboeuf
Dermatology
Referral may be required

Brigham And Women's Fish Center For Women's Health

850 Boylston Street, Suite 402 Mass General Brigham Healthcare Center, 
Chestnut Hill, MA 
 (1544.9 miles away)
617-632-6571
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Nicole Leboeuf is a Dermatologist practicing medicine in Chestnut Hill, Massachusetts. Dr. Leboeuf is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Lymphomatoid Papulosis. Dr. Leboeuf is board certified in Dermatology.

Frequently Asked Questions about Dr. Joseph Merola

How do I make an appointment with Dr. Joseph Merola?

You can book an appointment with Dr. Joseph Merola by calling their office at 617-732-4918. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Joseph Merola a top-rated expert for Psoriasis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Joseph Merola is classified as an Elite expert for Psoriasis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Joseph Merola specialize in?

While Dr. Joseph Merola is a Dermatology, they have specific expertise in Psoriasis, Psoriatic Arthritis, and Cutaneous Lupus Erythematosus (CLE). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Dermatology.

Does Dr. Joseph Merola participate in research or clinical trials?

Yes. Dr. Joseph Merola has published 435 articles and abstracts on conditions like Psoriasis. You can view a list of Dr. Joseph Merola's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Joseph Merola accept my insurance?

Dr. Joseph Merola accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-732-4918 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Merola's expertise for a condition
ConditionClose
View All 11 Elite Conditions
View All 23 Advanced Conditions
View All 123 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile